Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$211K Buy
+1,129
New +$208K 0.07% 145
2024
Q3
Sell
-1,128
Closed -$261K 165
2024
Q2
$261K Hold
1,128
0.08% 165
2024
Q1
$243K Buy
+1,128
New +$264K 0.12% 76
2023
Q3
$294K Buy
+1,144
New +$306K 0.17% 91
2023
Q2
Sell
-1,146
Closed -$319K 103
2023
Q1
$319K Sell
1,146
-12,612
-92% -$3.49M 0.19% 88
2022
Q4
$4.25M Buy
13,758
+12,572
+1,060% +$3.55M 2.74% 11
2022
Q3
$317K Sell
1,186
-13
-1% -$2.76K 0.23% 84
2022
Q2
$245K Buy
+1,199
New +$245K 0.17% 101
2021
Q4
$296K Buy
+1,144
New +$294K 0.35% 44

Other funds holding BIIB

Tradewinds LLC's BIIB Position: Q1 2026 in Review

Tradewinds LLC opened a new position in Biogen (BIIB) in Q1 2026: 1,129 shares worth $211K. The stake represents 0.07% of the portfolio and ranks #145 among its holdings. This is a return to the name: Tradewinds LLC previously reported a position in BIIB as recently as Q2 2024.

Tradewinds LLC first reported a position in BIIB in Q4 2021 and has held it in 9 quarters since. The position peaked at $4.25M in Q4 2022. 1,004 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Tradewinds LLC held 1,129 shares of Biogen worth $211K as of Q1 2026.
  • Biogen was a new Tradewinds LLC position in Q1 2026.
  • Biogen made up 0.07% of Tradewinds LLC's portfolio in Q1 2026, its #145 holding.
  • Tradewinds LLC first reported a position in Biogen in Q4 2021 and has held it in 9 quarters since.
  • Tradewinds LLC's Biogen position peaked at $4.25M in Q4 2022.
  • 1,004 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Tradewinds LLC's 13F filing for Q1 2026, filed 4 May 2026.